UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

July 13, 2012

SRKP 16, INC.

(Exact name of registrant as specified in its charter)

5777 West Century Blvd., Suite 360B

 Los Angeles, California 90045

 (Address of principal executive offices)

(310) 359-1680

(Issuer’s Telephone Number)

4737 North Ocean Drive, Suite 207

Lauderdale by the Sea, FL 33308

 (Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

1

The following sets forth the information required by Item 701 of Regulation S-K with respect to the unregistered sales of equity securities by SRKP 16, Inc., a Delaware corporation (the "Company"):

1.a.

Effective July 13, 2012, the Company sold an aggregate of 280,000 Units of its Securities, each Unit consisting of one (1) Share of Common Stock, $0.001 par value and two (2) Common Stock Purchase Warrants (collectively the “Securities”) for a purchase price of $1.00 per Unit.  One Warrant is exercisable for five years to purchase an additional share of Common Stock for $1.50 per share; and, one Warrant is exercisable for five years to purchase an additional share of Common Stock for $2.00 per share.

b.

The Units were sold to ten (10) persons each of whom qualified as an “accredited investor” within the meaning of Rule 501(c) of Regulation D.  The Common Stock and Warrants issued were “restricted securities” under the Securities Act of 1933, as amended and the certificate evidencing same bears the Company’s customary restrictive legend.

c.

The Company paid a sales commission of $28,000 (10% of the gross proceeds of the Units sold), a non-accountable expense allowance of $8,400 (3% of gross proceeds) and 10% warrant coverage on all Securities sold to two broker-dealer firms.

d.

The sale of the Securities was undertaken without registration under the Securities Act in reliance upon an exemption from the registration requirements of the Securities Act set forth in Rule 506 of Regulation D thereunder.  In addition, the Securities, which were taken for investment purposes and not for resale, were subject to restrictions on transfer.  We did not engage in any public advertising or general solicitation in connection with this transaction, and we provided the investor with disclosure of all aspects of our business, including providing the investor with our reports filed with the Securities and Exchange Commission and other financial, business and corporate information.  Based on our investigation, we believed that each accredited investor obtained all information regarding the Company that was requested, received answers to all questions posed and otherwise understood the risks of accepting our Securities for investment purposes.

e.

See paragraph 1(a) above

f.

The net proceeds from the sale of Units, after deducting the commission, the non-accountable expense allowance and expenses of the Offering, were $243,600 and will be used for working capital.

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.